ITM Secures Up to $262.5M in Financing from Blue Owl
ITM secures up to $262.5M from Blue Owl to support the commercialization of ITM-11 and expand its radiopharmaceutical pipeline.
Health Policy in the Spotlight: German Medical Assembly in Leipzig
The 129th German Medical Assembly is bringing healthcare policy to Leipzig – with Health Minister Nina Warken and topics like AI, fee regulation, and abortion on the agenda.
Hope for Pulmonary Fibrosis Patients: New Drug Candidate Emerges
With Nerandomilast, Boehringer Ingelheim presents a groundbreaking drug candidate that could transform the treatment of pulmonary fibrosis. Phase III studies show first positive results in over a decade.
Court Overturns Ruling: FOCUS Doctor Seals Remain Valid
The Munich court has overturned the ban on FOCUS doctor seals—recommended physicians may continue to display their distinction publicly.
OTC Market 2025 Continues Growth
The OTC market saw solid growth again in 2024, affirming its role as a key pillar of Germany’s healthcare system. Every second medicine sold in pharmacies is now non-prescription.
Biotech: Startup Boom, Revenue Slump
Following a record year for startup funding in 2024, Germany’s biotech industry is now facing declining revenues and a sudden drop in investor interest in early 2025.
Public Concern Over Environmental Health Risks Declining, Says AOK Study
According to the latest WIdOmonitor by AOK, public awareness of environmental risks and their impact on health is steadily declining. Air pollution in particular is viewed with less concern.
Paul-Ehrlich-Institut Launches Digital Awareness Campaign Against Misinformation
The German Paul-Ehrlich-Institut is countering vaccine misinformation with a new digital campaign: #ImpfstoffFakten (VaccinationFacts) vs. Myths.